Raman Spectroscopic Investigation of Osteoclastic Activity under the Influence of Bisphosphonate

The bone resorption inhibitor bisphosphonate (BP) is used to prevent fractures in patients with osteoporosis and bone metastases caused by cancer. However, BP induces apoptosis of osteoclasts and excessively suppresses bone turnover, so that side effects such as jawbone necrosis have become a proble...

詳細記述

書誌詳細

出版年:	Applied Sciences
主要な著者:	Elia Marin, Tetsuya Adachi, Francesco Boschetto, Wenliang Zhu, Keiji Adachi, Narisato Kanamura, Toshiro Yamamoto, Giuseppe Pezzotti
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2022-04-01
主題:	bisphosphonate RANKL Raman spectroscopy osteoclasts
オンライン･アクセス:	https://www.mdpi.com/2076-3417/12/8/3757